DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol ▼ | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C1449563 | Cardiomyopathy, Familial Idiopathic | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0006826 | Malignant Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0026946 | Mycoses | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0001815 | Primary Myelofibrosis | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C4552003 | EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1 | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0008354 | Cholera | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0033578 | Prostatic Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C1306459 | Primary malignant neoplasm | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0002395 | Alzheimer's Disease | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0007103 | Malignant neoplasm of endometrium | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0476089 | Endometrial Carcinoma | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0341106 | Eosinophilic esophagitis | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0026850 | Muscular Dystrophy | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0024121 | Lung Neoplasms | PRG2 | 5553 | proteoglycan 2, pro eosinophil major basic protein | P13727 |
C0027877 | Neuronal Ceroid-Lipofuscinoses | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0027651 | Neoplasms | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0006826 | Malignant Neoplasms | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0017665 | Membranous glomerulonephritis | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0026764 | Multiple Myeloma | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0027819 | Neuroblastoma | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0026769 | Multiple Sclerosis | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C1306459 | Primary malignant neoplasm | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0019618 | Histiocytosis | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C0007758 | Cerebellar Ataxia | PPT2 | 9374 | palmitoyl-protein thioesterase 2 | Q9UMR5 |
C1850451 | CEROID LIPOFUSCINOSIS, NEURONAL, 1 | PPT1 | 5538 | palmitoyl-protein thioesterase 1 | P50897 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024